Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsInjectionStandard

NUTROPIN

SOMATROPIN [rDNA origin]

Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NUTROPIN is listed in Drugs@FDA under application 019676 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SOMATROPIN [rDNA origin] Form and strength Injectable; Injection - N/A Sponsor GENENTECH Submission history Latest submission status date: 2016-12-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview NUTROPIN is listed in Drugs@FDA under application 019676 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient SOMATROPIN [rDNA origin] Form and strength Injectable; Injection - N/A Sponsor GENENTECH Submission history Latest submission status date: 2016-12-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.